GT Biopharma (GTBP) had the highest return between 2001 and 2012 by a US stock, returning 162,366,499.3%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2001-2012 | 162,366,499.3% |
Cemtrex (CETX) | 2001-2012 | 6,791,020.23% |
Sequans Communications (SQNS) | 2001-2012 | 2,819,177.11% |
Hirequest (HQI) | 2001-2012 | 1,475,550% |
Zivo Bioscience (ZIVO) | 2001-2012 | 1,341,076.47% |
Castellum (CTM) | 2001-2012 | 815,117.39% |
Perspective Therapeutics (CATX) | 2001-2012 | 259,900% |
India Globalization Capital (IGC) | 2001-2012 | 233,233.33% |
NextTrip (NTRP) | 2001-2012 | 231,900% |
Ring Energy (REI) | 2001-2012 | 195,233.33% |
QXO (QXO) | 2001-2012 | 115,105% |
Taoping (TAOP) | 2001-2012 | 109,107.28% |
ProMIS Neurosciences (PMN) | 2001-2012 | 54,572.9% |
Aris Mining (ARMN) | 2001-2012 | 52,895.39% |
Franklin Wireless (FKWL) | 2001-2012 | 31,401.59% |
Alto Ingredients (ALTO) | 2001-2012 | 26,715.64% |
Ocean Power Technologies (OPTT) | 2001-2012 | 23,678.89% |
Monster Beverage (MNST) | 2001-2012 | 22,083.12% |
MEDIFAST (MED) | 2001-2012 | 18,675.38% |
Cementos Pacasmayo SAA ADR (CPAC) | 2001-2012 | 17,249.33% |
DeFi Technologies (DEFT) | 2001-2012 | 15,650% |
DXP Enterprises (DXPE) | 2001-2012 | 15,602.4% |
Nixxy (NIXX) | 2001-2012 | 13,954.05% |
PharmaCyte Biotech (PMCB) | 2001-2012 | 12,610% |
Metalla Royalty & Streaming (MTA) | 2001-2012 | 11,775% |
